Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for Sedation and Analgesia in Septic Patients Under Invasive Mechanical Ventilation
NCT07556172Phase 4Active, not recruiting
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Jan 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esketamine in sepsis, sponsored by The Second Affiliated Hospital of Nanchang University. Started Jan 2025; status: active, not recruiting.
02
Drugs
esketamine
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT07556172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07556172.